Literature DB >> 6973595

Genetic control of antinuclear antibodies in mice inoculated with the moloney leukaemia virus.

D Piatier, P Debre, P S Mach, S Gisselbrecht.   

Abstract

The production of antinuclear antibodies (ANA) was studied after inoculation with Moloney leukaemia virus (M-MuLV) in different H-2 congenic strains of mice. Using a new sensitive method for ANA detection, it was demonstrated that M-MuLV-induced ANA were genetically controlled by several different factors. A high viral production was first required for ANA triggering. Among viremic animals both high and low ANA producers were observed. H-2 and non H-2-linked genes were involved in the control of M-MuLV-induced ANA; these genes were different from those involved in the control of viremia. The H2b haplotype was associated with an increased ANA response, the transmission of the responder phenotype being intermediate. Non-H-2-linked genes must also control M-MuLV-induced ANA, as demonstrated in mice having the same H-2 haplotypes, since with equivalent viremias they produced different amounts of ANA. No linkage with X chromosome was found.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973595     DOI: 10.1111/j.1744-313x.1981.tb00755.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  2 in total

1.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

2.  The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.

Authors:  P S Mach; H Brouilhet; B Amor
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.